Amanote Research
Register
Sign In
An Overview of the Use of High-Dose Melphalan With Autologous Stem Cell Transplantation for the Treatment of AL Amyloidosis
Bone Marrow Transplantation
- United Kingdom
doi 10.1038/sj.bmt.1703200
Full Text
Open PDF
Abstract
Available in
full text
Categories
Transplantation
Hematology
Date
October 1, 2001
Authors
V Sanchorawala
DG Wright
DC Seldin
LM Dember
K Finn
RH Falk
J Berk
K Quillen
M Skinner
Publisher
Springer Science and Business Media LLC
Related search
The Effect of Bone Marrow Plasma Cell Burden on Survival in Patients With Light Chain Amyloidosis Undergoing High-Dose Melphalan and Autologous Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Stem Cell Transplantation Compared With Melphalan Plus Dexamethasone in the Treatment of Immunoglobulin Light-Chain Amyloidosis
Cancer
Cancer Research
Oncology
A Second Course of High-Dose Melphalan and Auto-SCT for the Treatment of Relapsed AL Amyloidosis
Bone Marrow Transplantation
Transplantation
Hematology
Autologous Stem Cell Transplantation in Patients With AL Amyloidosis With Impaired Renal Function
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Clinical Characteristics and Treatment Results of Pediatric Osteosarcoma: The Role of High Dose Chemotherapy With Autologous Stem Cell Transplantation
Cancer Research and Treatment
Cancer Research
Oncology
MBL2 Polymorphism and Risk of Severe Infections in Multiple Myeloma Patients Receiving High-Dose Melphalan and Autologous Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
High Dose Melphalan, BCNU and Etoposide With Autologous Bone Marrow Transplantation for Hodgkin's Disease
British Journal of Cancer
Cancer Research
Oncology
